Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enzastaurin in recurrent ovarian or primary peritoneal carcinoma
NCT00420381Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jan 2007
- Primary completion
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of enzastaurin in ovarian carcinoma, primary peritoneal carcinoma (PPC), sponsored by Eli Lilly and Company. Started Jan 2007; status: completed.
02
Drugs
enzastaurin
03
Conditions
ovarian carcinomaprimary peritoneal carcinoma (PPC)
Beyond the preview
Go deeper on NCT00420381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00420381.